NL7312776A - - Google Patents

Info

Publication number
NL7312776A
NL7312776A NL7312776A NL7312776A NL7312776A NL 7312776 A NL7312776 A NL 7312776A NL 7312776 A NL7312776 A NL 7312776A NL 7312776 A NL7312776 A NL 7312776A NL 7312776 A NL7312776 A NL 7312776A
Authority
NL
Netherlands
Application number
NL7312776A
Other versions
NL152246B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7312776A publication Critical patent/NL7312776A/xx
Publication of NL152246B publication Critical patent/NL152246B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL737312776A 1972-09-18 1973-09-17 Werkwijze voor het bereiden van een preparaat met anti-aritmische activiteit, gevormd preparaat en werkwijze voor het bereiden van een daartoe geschikte verbinding. NL152246B (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4315072 1972-09-18
GB998773*[A GB1405444A (en) 1972-09-18 1973-03-01 2-aminoindane derivatives
GB998873 1973-03-01
GB1030373 1973-03-02

Publications (2)

Publication Number Publication Date
NL7312776A true NL7312776A (sv) 1974-03-20
NL152246B NL152246B (nl) 1977-02-15

Family

ID=27447738

Family Applications (1)

Application Number Title Priority Date Filing Date
NL737312776A NL152246B (nl) 1972-09-18 1973-09-17 Werkwijze voor het bereiden van een preparaat met anti-aritmische activiteit, gevormd preparaat en werkwijze voor het bereiden van een daartoe geschikte verbinding.

Country Status (13)

Country Link
JP (1) JPS5327263B2 (sv)
AR (4) AR206505A1 (sv)
CA (1) CA992547A (sv)
CH (1) CH585690A5 (sv)
DD (2) DD109802A5 (sv)
ES (3) ES418827A1 (sv)
FR (1) FR2199988B1 (sv)
GB (1) GB1405444A (sv)
HU (1) HU168018B (sv)
IL (1) IL43218A (sv)
LU (1) LU68426A1 (sv)
MX (1) MX3233E (sv)
NL (1) NL152246B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975461A (en) * 1986-06-19 1990-12-04 E. R. Squibb & Sons, Inc. P-aminophenols, derivatives thereof and method of use
JPH0293610U (sv) * 1989-01-09 1990-07-25
ATE335482T1 (de) * 1999-06-10 2006-09-15 Bridge Pharma Inc Dermale anästhetika
EP1658847A3 (en) * 1999-06-10 2006-07-26 Bridge Pharma, Inc. Indane derivatives as dermal anesthetic agents
HUP0104841A3 (en) 1999-09-17 2002-07-29 Daiichi Suntory Pharma Co Ltd Medicaments containing benzoquinone- or condensed pyrimidine derivatives as active ingredient for treating of myocarditis, dilated cardiomyopathy and cardiac insufficiency
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
CA2655809C (en) 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds

Also Published As

Publication number Publication date
FR2199988B1 (sv) 1977-11-25
AR205891A1 (es) 1976-06-15
DD109802A5 (sv) 1974-11-20
AR206505A1 (es) 1976-07-30
GB1405444A (en) 1975-09-10
IL43218A (en) 1977-05-31
ES440029A1 (es) 1977-02-16
IL43218A0 (en) 1973-11-28
DE2346337A1 (de) 1974-04-04
HU168018B (sv) 1976-02-28
ES418827A1 (es) 1977-02-01
NL152246B (nl) 1977-02-15
JPS5327263B2 (sv) 1978-08-07
AR204247A1 (es) 1975-12-10
AU6028373A (en) 1975-03-13
MX3233E (es) 1980-08-05
JPS4969648A (sv) 1974-07-05
CA992547A (en) 1976-07-06
CH585690A5 (sv) 1977-03-15
DE2346337B2 (de) 1976-08-26
FR2199988A1 (sv) 1974-04-19
AR203500A1 (es) 1975-09-15
LU68426A1 (sv) 1973-11-26
DD108277A5 (sv) 1974-09-12
ES440030A1 (es) 1977-02-16

Similar Documents

Publication Publication Date Title
JPS5611349B2 (sv)
FR2199988A1 (sv)
JPS5129779B2 (sv)
JPS4886877A (sv)
JPS525317B2 (sv)
CH572682A5 (sv)
CH572651A5 (sv)
CH572363A5 (sv)
CH572102A5 (sv)
CH571764A5 (sv)
CH570503A5 (sv)
CH569167A5 (sv)
CH565978A5 (sv)
CH565301A5 (sv)
CH565246A5 (sv)
CH561786A5 (sv)
CH557907A (sv)
CH546010A (sv)
CH545741A (sv)
CH545715A (sv)
CH1809873A4 (sv)
BG22072A3 (sv)
BG18499A1 (sv)
BG18106A1 (sv)
CH574595A5 (sv)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: CHRISTIAENS